← Back to headlines
Basilea Pharmaceutica Reports GAAP EPS of CHF 2.13 and Revenue of CHF 118.99M
Basilea Pharmaceutica AG announced its GAAP EPS of CHF 2.13 and revenue of CHF 118.99 million.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Asian Markets Fall and Oil Prices Rise Amid Escalating US-Iran Tensions
1h ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
1h ago
Apple Sets Executive Pay for New CEO John Ternus and Chair Tim Cook
1h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
2h ago